OPHLF Stock Latest News
Company AnnouncementsONO Pharmaceutical Details Q2 FY2026 Results and Pipeline Status1w ago
Company AnnouncementsONO Pharmaceutical Lifts Profits Despite Revenue Decline, Maintains Dividend Outlook1w ago
Company AnnouncementsONO Pharmaceutical’s Alzheimer’s Trial Milestone: What ONO‑2020 Could Mean for OPHLF Investors2w agoOPHLF
Company AnnouncementsOno Pharma Advances Pediatric Epilepsy Trial, Bolstering Long-Term Growth Story3w agoOPHLF- Company AnnouncementsOno’s New Pediatric Cancer Trial Signals Steady Pipeline Progress for O.P.H.L.F Investors1M agoOPHLF
Company AnnouncementsONO’s New Sjogren’s Trial Adds Quiet Upside to OPHLF’s Pipeline1M agoOPHLFCompany AnnouncementsBladder Cancer Trial Completion Puts Opdivo in Focus for BMY and Ono Investors1M agoBMY
Company AnnouncementsOno Pharma’s New Cancer Trial Adds Early-Stage Upside—and Risk—for OPHLF Investors2M agoOPHLF
Company AnnouncementsONO-6414: New First-in-Human Ulcerative Colitis Study Puts ONO Pharmaceutical on Investors’ Radar3M agoOPHLF
Company AnnouncementsONO Pharmaceutical Q1: Record Sales, Margin Strain3M ago
Company AnnouncementsOno Pharmaceutical Lifts Q1 Profits Despite Revenue Decline, Confirms FY2026 Outlook3M ago
Company AnnouncementsOno Pharma Halts Early Lymphoma Trial, Raising Fresh Questions for Investors3M agoOPHLF
Pre-EarningsOPHLF Upcoming Earnings Report: What to Expect?3M agoCompany AnnouncementsOno’s New GIST Study Puts Early‑Stage Oncology Back in Focus for OPHLF Investors3M agoOPHLF
Company AnnouncementsOno Pharma’s ONO-1110 Pain Trial Reaches Completion, Setting Up a Key Readout3M agoOPHLF
Company AnnouncementsONO-1110 Depression Trial Completion: What It Means for OPHLF Investors4M agoOPHLF- Company AnnouncementsONO’s ONO‑1110 Trial Completion Puts Social Anxiety Bet in Investor Focus4M agoOPHLF
Company AnnouncementsONO’s Tirabrutinib Liver Study Completion: What It Means for OPHLF Investors4M agoOPHLF- Company AnnouncementsReal-World Data on Nivolumab Plus Chemo in Japanese Gastric Cancer: What Investors Should Watch4M agoBMY
Company AnnouncementsOno’s ONO-4578 Breast Cancer Combo Clears Phase I Milestone, Setting Up the Next Investor Catalyst5M agoOPHLFCompany AnnouncementsOno’s Real-World Tirabrutinib Study in Taiwan Reaches Completion, Setting Up a New Catalyst for OPHLF5M agoOPHLF
